Israel - English - Ministry of Health

gsk consumer healthcare, israel ltd - diclofenac sodium - gel - diclofenac sodium 1 % - diclofenac - self medication for the following indications: local treatment of pain, inflammation and swelling due to: • pain and inflammation and swelling in trauma of the tendons, ligaments, muscles and joints, e.g. due to sprains, strains and bruises and/or backache (e.g. sports injuries). • localized forms of soft tissue rheumatism such as tendonitis (e.g.tennis elbow), bursitis.by physicians order :• pain caused by osteoarthrosis of the peripheral joints, as of the knee or fingers

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - diclofenac sodium -

Malta - English - Medicines Authority

novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - diclofenac sodium - suppository - diclofenac sodium 50 mg - antiinflammatory and antirheumatic products

Malta - English - Medicines Authority

novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - diclofenac sodium - suppository - diclofenac sodium 12.5 mg - antiinflammatory and antirheumatic products

Malta - English - Medicines Authority

novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - diclofenac sodium - suppository - diclofenac sodium 100 mg - antiinflammatory and antirheumatic products

Australia - English - Department of Health (Therapeutic Goods Administration)

alcon laboratories australia pty ltd - diclofenac sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis consumer health australasia pty ltd - diclofenac potassium -

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 25mg;  ;   - enteric coated tablet - 25 mg - active: diclofenac sodium 25mg     excipient: ammonia solution colloidal silicon dioxide hypromellose   silicone antifoam emulsion (enteric-coat)   pigment suspension white   pigment suspension white (colour-coat) lactose monohydrate macrogol 8000 magnesium stearate maize starch methacrylic acid copolymer microcrystalline cellulose polyethylene glycol hydrogenated castor oil   povidone purified talc     purified water     sodium starch glycolate - treatment of: inflammatory and degenerative forms of rheumatism - rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism; acute attacks of gout; post-traumatic and postoperative pain, inflammation, and swelling, e.g. following dental or orthopaedic surgery; painful and/or inflammatory conditions in gynaecology, e.g. primary dysmenorrhoea or adnexitis; as an adjuvant in severe painful inflammatory infections of the ear, nose, or throat, e.g. pharyngotonsillitis, otitis. in keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. fever alone is not an indication.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 50mg;  ;   - enteric coated tablet - 50 mg - active: diclofenac sodium 50mg     excipient: colloidal silicon dioxide hypromellose   silicon antifoam emulsion se2, enteric coat iron oxide red   iron oxide yellow   lactose monohydrate macrogol 8000 magnesium stearate maize starch methacrylic acid copolymer microcrystalline cellulose polyethylene glycol hydrogenated castor oil   povidone purified talc   sodium starch glycolate titanium dioxide   - treatment of: inflammatory and degenerative forms of rheumatism - rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism; acute attacks of gout; post-traumatic and postoperative pain, inflammation, and swelling, e.g. following dental or orthopaedic surgery; painful and/or inflammatory conditions in gynaecology, e.g. primary dysmenorrhoea or adnexitis; as an adjuvant in severe painful inflammatory infections of the ear, nose, or throat, e.g. pharyngotonsillitis, otitis. in keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. fever alone is not an indication.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 25 mg/ml;   - solution for injection - 75mg/3ml - active: diclofenac sodium 25 mg/ml   excipient: benzyl alcohol mannitol propylene glycol sodium hydroxide sodium metabisulfite water for injection - treatment of biliary colic.